Q4 2024 Certara Inc Earnings Call Transcript
Key Points
- Certara Inc (CERT) achieved a 9% revenue growth in 2024, reaching $385.1 million, with strong performance in both software and services.
- Fourth-quarter bookings increased by 22% year-over-year, driven by a 38% growth in software bookings and a 12% growth in services bookings.
- The company successfully integrated recent acquisitions, including Chemaxon, which contributed $6.6 million to fourth-quarter revenue.
- Certara expanded its customer base to over 2,400 life sciences companies, with significant growth in customers with annual contract values exceeding $100,000 and $1 million.
- Certara's focus on biosimulation and model-informed drug development (MIDD) continues to gain traction, with strong adoption across the biopharmaceutical industry.
- Certara faced cautious spending behavior from customers due to funding constraints, Medicare drug price negotiations, and geopolitical uncertainties.
- Decision-making timelines among customers have been elongated, impacting the predictability of demand for Certara's services.
- The software net retention rate decreased to 106% in the fourth quarter, attributed to spending patterns and slower decision-making among Tier 1 customers.
- Regulatory writing revenue declined in 2024, although it showed signs of recovery in the fourth quarter.
- Certara's guidance for 2025 assumes a similar market environment to 2024, with potential challenges in clinical R&D spending and customer decision-making processes.
Good day, and thank you for standing by. Welcome to the Certara fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, David Deuchler of Investor Relations. Please go ahead.
Good afternoon, everyone. Thank you all for participating in today's conference call. On the call from Certara, we have William Feehery, Chief Executive Officer; and John Gallagher, Chief Financial Officer.
Earlier today, Certara released financial results for the full year ended December 31, 2024. Copy of the press release is available on the company's website.
Before we begin, I would like to remind you that management will make statements during this call that includes forward-looking statements, and actual results may differ materially from those expressed or implied in the forward-looking statements. Please refer to slide 2 in the accompanying materials for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
